These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35400349)

  • 1. Targeting Signaling Pathway by Curcumin in Osteosarcoma.
    Farnood PR; Pazhooh RD; Asemi Z; Yousefi B
    Curr Mol Pharmacol; 2023; 16(1):71-82. PubMed ID: 35400349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma.
    Lu KH; Lu PW; Lu EW; Lin CW; Yang SF
    Int J Biol Sci; 2023; 19(4):1241-1265. PubMed ID: 36923933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
    Leow PC; Bahety P; Boon CP; Lee CY; Tan KL; Yang T; Ee PL
    Eur J Med Chem; 2014 Jan; 71():67-80. PubMed ID: 24275249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin in human osteosarcoma: From analogs to carriers.
    Lu KH; Lu PW; Lin CW; Yang SF
    Drug Discov Today; 2023 Feb; 28(2):103437. PubMed ID: 36372327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers.
    Gota VS; Maru GB; Soni TG; Gandhi TR; Kochar N; Agarwal MG
    J Agric Food Chem; 2010 Feb; 58(4):2095-9. PubMed ID: 20092313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Multifaceted Therapeutic Mechanisms of Curcumin in Osteosarcoma: State-of-the-Art.
    Zahedipour F; Bolourinezhad M; Teng Y; Sahebkar A
    J Oncol; 2021; 2021():3006853. PubMed ID: 34671398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin Analog DK1 Induces Apoptosis in Human Osteosarcoma Cells In Vitro through Mitochondria-Dependent Signaling Pathway.
    Aziz MNM; Hussin Y; Che Rahim NF; Nordin N; Mohamad NE; Yeap SK; Yong CY; Masarudin MJ; Cheah YK; Abu N; Akhtar MN; Alitheen NB
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29303982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.
    Ma Y; Ren Y; Han EQ; Li H; Chen D; Jacobs JJ; Gitelis S; O'Keefe RJ; Konttinen YT; Yin G; Li TF
    Biochem Biophys Res Commun; 2013 Feb; 431(2):274-9. PubMed ID: 23291185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling.
    Li Y; Zhang J; Ma D; Zhang L; Si M; Yin H; Li J
    FEBS J; 2012 Jun; 279(12):2247-59. PubMed ID: 22521131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Signaling Pathways as Potential Therapeutic Targets in Osteosarcoma.
    Dana PM; Sadoughi F; Asemi Z; Yousefi B
    Curr Med Chem; 2022; 29(25):4436-4444. PubMed ID: 35139778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schisandrin B suppresses osteosarcoma lung metastasis
    Wang Y; Chen J; Huang Y; Yang S; Tan T; Wang N; Zhang J; Ye C; Wei M; Luo J; Luo X
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy.
    Angulo P; Kaushik G; Subramaniam D; Dandawate P; Neville K; Chastain K; Anant S
    J Hematol Oncol; 2017 Jan; 10(1):10. PubMed ID: 28061797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells.
    Leow PC; Tian Q; Ong ZY; Yang Z; Ee PL
    Invest New Drugs; 2010 Dec; 28(6):766-82. PubMed ID: 19730790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells.
    Lee DS; Lee MK; Kim JH
    Anticancer Res; 2009 Dec; 29(12):5039-44. PubMed ID: 20044614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic effects of curcumin on human osteosarcoma U2OS cells.
    Jin S; Xu HG; Shen JN; Chen XW; Wang H; Zhou JG
    Orthop Surg; 2009 May; 1(2):144-52. PubMed ID: 22009832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway.
    Hamzehzadeh L; Atkin SL; Majeed M; Butler AE; Sahebkar A
    J Cell Physiol; 2018 Oct; 233(10):6530-6537. PubMed ID: 29693253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aclidinium bromide inhibits proliferation of osteosarcoma cells through regulation of PI3K/Akt pathway.
    Li ZZ; Wang YL; Yu YH; Xing YL; Ji XF
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):105-112. PubMed ID: 30657552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation and LEF1 translation.
    Hu S; Chang J; Ruan H; Zhi W; Wang X; Zhao F; Ma X; Sun X; Liang Q; Xu H; Wang Y; Yang Y
    Int J Biol Sci; 2021; 17(10):2504-2522. PubMed ID: 34326690
    [No Abstract]   [Full Text] [Related]  

  • 19. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway.
    Liu W; Zhao Z; Wang Y; Li W; Su Q; Jia Q; Zhang J; Zhang X; Shen J; Yin J
    Cell Death Dis; 2018 Mar; 9(3):343. PubMed ID: 29497056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
    Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.